10X GENOMICS (Germany) Probability of Future Stock Price Finishing Over 17.87
| 1KJ Stock | EUR 12.61 0.07 0.56% |
10X |
10X GENOMICS Target Price Odds to finish over 17.87
The tendency of 10X Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over € 17.87 or more in 90 days |
| 12.61 | 90 days | 17.87 | about 10.96 |
Based on a normal probability distribution, the odds of 10X GENOMICS to move over € 17.87 or more in 90 days from now is about 10.96 (This 10X GENOMICS DL probability density function shows the probability of 10X Stock to fall within a particular range of prices over 90 days) . Probability of 10X GENOMICS DL price to stay between its current price of € 12.61 and € 17.87 at the end of the 90-day period is about 76.11 .
Assuming the 90 days horizon 10X GENOMICS DL has a beta of -0.7. This suggests as returns on the benchmark increase, returns on holding 10X GENOMICS are expected to decrease at a much lower rate. During a bear market, however, 10X GENOMICS DL is likely to outperform the market. Additionally 10X GENOMICS DL has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. 10X GENOMICS Price Density |
| Price |
Predictive Modules for 10X GENOMICS
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as 10X GENOMICS DL. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.10X GENOMICS Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. 10X GENOMICS is not an exception. The market had few large corrections towards the 10X GENOMICS's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold 10X GENOMICS DL, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of 10X GENOMICS within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.59 | |
β | Beta against Dow Jones | -0.7 | |
σ | Overall volatility | 2.23 | |
Ir | Information ratio | -0.12 |
10X GENOMICS Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of 10X GENOMICS for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for 10X GENOMICS DL can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| 10X GENOMICS DL generated a negative expected return over the last 90 days | |
| 10X GENOMICS DL has high historical volatility and very poor performance | |
| The company reported the revenue of 503.71 M. Net Loss for the year was (504.02 M) with profit before overhead, payroll, taxes, and interest of 416.4 M. | |
| 10X GENOMICS DL has accumulated about 621.96 M in cash with (219.4 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.66. | |
| Over 100.0% of the company shares are owned by institutions such as pension funds |
10X GENOMICS Technical Analysis
10X GENOMICS's future price can be derived by breaking down and analyzing its technical indicators over time. 10X Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of 10X GENOMICS DL. In general, you should focus on analyzing 10X Stock price patterns and their correlations with different microeconomic environments and drivers.
10X GENOMICS Predictive Forecast Models
10X GENOMICS's time-series forecasting models is one of many 10X GENOMICS's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary 10X GENOMICS's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about 10X GENOMICS DL
Checking the ongoing alerts about 10X GENOMICS for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for 10X GENOMICS DL help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| 10X GENOMICS DL generated a negative expected return over the last 90 days | |
| 10X GENOMICS DL has high historical volatility and very poor performance | |
| The company reported the revenue of 503.71 M. Net Loss for the year was (504.02 M) with profit before overhead, payroll, taxes, and interest of 416.4 M. | |
| 10X GENOMICS DL has accumulated about 621.96 M in cash with (219.4 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.66. | |
| Over 100.0% of the company shares are owned by institutions such as pension funds |
Other Information on Investing in 10X Stock
10X GENOMICS financial ratios help investors to determine whether 10X Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 10X with respect to the benefits of owning 10X GENOMICS security.